By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Breath Therapeutics Holding BV 



Paris      France
Phone: n/a Fax: n/a


SEARCH JOBS

Breath Therapeutics is specializing in advanced and first-in-class inhalation therapies for severe respiratory diseases. For its clinical development, the company is using proprietary drug formulations optimized for inhaled administration with exclusively licenced, high performance nebulizers. Breath Therapeutics is focussing on integrated therapy solutions in the interaction between diagnostic, therapy and eHealth therapy control. The clinical development program is addressing the treatment of Bronchiolitis Obliterans Syndrome (BOS) in patients after lung transplantation. PARI Pharma, a leading nebulizer company, is strategic partner and technology licensee for the BOS development program. Breath Therapeutics is based in Munich and Frankfurt, Germany.

YEAR FOUNDED:

2005

LEADERSHIP:

CEO: Jens Stegemann

CFO: Anne Burger

CSO: Gerhard Boerner

COO: Oliver Denk


Key Statistics


Email: contact@breath-therapeutics.com
Ownership: Private

Web Site: Breath Therapeutics Holding BV
Employees:
Symbol: 
 



Industry
Medical Device






Company News
//-->